04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
While office holiday parties provide employees with an opportunity to celebrate a successful year wi...
Read More >
After a delay of several months, Congress passed the Setting Every Community Up for Retirement Enhan...
Read More >
The U.S. oil and gas industry has witnessed significant transformations over the last year, and 2020...
Read More >
Plan sponsors with their proprietary funds have a unique problem. Using proprietary funds will lead ...
Read More >
In view of the impact of the COVID-19 pandemic on the economy, landlords are increasingly concerned ...
Read More >
Whether used for air travel, at sporting events, or during workouts at gyms, the popularity of headp...
Read More >